Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients.
Ghaznavi H, Mohammadghasemipour Z, Shirvaliloo M, Momeni MK, Metanat M, Gorgani F, Abedipour F, Mohammadi M, Sartipi M, Khorashad ARS, Shahraki O, Ataee M, Sheervalilou R, Sargazi S.
Ghaznavi H, et al. Among authors: metanat m.
Inflammopharmacology. 2022 Oct;30(5):1645-1657. doi: 10.1007/s10787-022-01029-4. Epub 2022 Jul 14.
Inflammopharmacology. 2022.
PMID: 35834150
Free PMC article.